[ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/provenance", "@graph": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/assertion", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2026-06-30T21:07:00.755142+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0001-8327-0142" } ] } ] }, { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/assertion", "@graph": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/_b1", "http://schema.org/alternateName": [ { "@value": "gaval" } ], "http://schema.org/identifier": [ { "@value": "short_name" } ], "@type": [ "https://w3id.org/peh/terms/ContextAlias" ], "https://w3id.org/peh/terms/hasContext": [ { "@id": "https://ror.org/04gq0w522" } ] }, { "@id": "https://w3id.org/peh/biochementities/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo", "http://purl.org/dc/terms/isPartOf": [ { "@id": "https://w3id.org/spaces/biochementity/r/vocabulary" } ], "http://schema.org/alternateName": [ { "@value": "GAVal" }, { "@language": "nl-be", "@value": "GAVal" } ], "http://schema.org/comment": [ { "@value": "comments: Should parent compound not be acrylamide? feedback_epi team: Yes assigning Acrylamide as parent compound seems correct to me. Because Acrylamide is the substance a human is exposed to, and we can measure GAVAL and AAVAL to reflect that exposure. GA‑Val (GAVAL) and AA‑Val (AAVAL) — are both well‑established biomarkers of exposure to acrylamide and its metabolite glycidamide. These adducts form when the reactive compounds bind to the N‑terminal valine of hemoglobin. Core attribution - AAVAL (N‑(2‑carbamoylethyl)valine) reflects exposure to acrylamide, the parent compound. - GAVAL (N‑(2‑carbamoyl‑2‑hydroxyethyl)valine) reflects exposure to glycidamide, which is the epoxide metabolite formed when acrylamide is metabolized via CYP2E1. This relationship is well documented: acrylamide is converted to glycidamide, and both acrylamide and glycidamide form hemoglobin adducts that can be used to reconstruct exposure. source: https://pmc.ncbi.nlm.nih.gov/articles/PMC5696489/ Moreover, AA and GA react with plasma and other proteins, such as hemoglobin (Hb). Covalent binding to the N-terminal valine (Val) residue of Hb results in formation of N-(2-carbamoylethyl)valine (AAVal) and N-(2-carbamoyl-2-hydroxyethyl)valine (GAVal) Hb adducts that can be specifically cleaved off and derivatized to serve as biomarkers for long-term exposure monitoring (Bergmark et al. 1993; EFSA 2015; Fennell et al. 2005)." } ], "@type": [ "http://www.w3.org/2002/07/owl#Class" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "N-(2-Carbamoyl-2-hydroxyethyl)valine" }, { "@language": "nl-be", "@value": "N-(2-carbamoyl-2-hydroxyethyl)valine" } ], "http://www.w3.org/2000/01/rdf-schema#subClassOf": [ { "@id": "https://w3id.org/peh/terms/BioChemEntity" } ], "https://w3id.org/peh/terms/hasContextAlias": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/_b1" } ], "https://w3id.org/peh/terms/hasGroupLabel": [ { "@value": "acrylamide" } ], "https://w3id.org/peh/terms/isMetaboliteOf": [ { "@id": "https://w3id.org/peh/biochementities/RAzsgNFMlmFl21D1kjAVEf39Z8wXIoed404LTxxTXi4OU" } ] } ] }, { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/Head", "@graph": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/pubinfo", "@graph": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo", "http://purl.org/dc/terms/license": [ { "@id": "https://creativecommons.org/licenses/by/4.0/" } ], "http://purl.org/nanopub/x/hasNanopubType": [ { "@id": "https://w3id.org/peh/terms/BioChemEntity" } ], "http://purl.org/nanopub/x/introduces": [ { "@id": "https://w3id.org/peh/biochementities/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo" } ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "N-(2-Carbamoyl-2-hydroxyethyl)valine" } ], "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2026-06-30T21:07:00.755142+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://w3id.org/np/RAWDFdbuQxoc9NE7suv9ZPpGeQJ4h_QVL67iJy5ZFaCYA/biochementity-bot" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "https://w3id.org/np/RAhSlIuuw5YqmMoyyvmy5GL3qIhs7sp14i6x2y3DCOhXM" } ] }, { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo/sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEArwKYgWZTyvZqlmCnnhp2LFM62fX6ZMq4EJ92Oea5H7vHoPOftYej+zS3Vi95eMLZ+RCGd0mNZ0x2+n2rYdGqf/R+9VesqVAjrhGECXLwF3t84VbysGYgiOd5m4YPpzzcgRHpBjYjK86+hR7hqc+y0ai36tYp165WhuaXbnWY5apw8aUN9Q5e1Daid70PST0Hri9dV/Eq4mxbogXlzJbgduIVOwQMyYlGLrb+NyLDpFT+8VpPs+vblnFTF0xwIrcA11O0Mv/WqCfyrtA77nxtc4gY9RkES+2vaEUuCzxbDleUL/JmxOxSI8Cl0LtgBcRZpD7wppe4sIp3CsuK4a5J2QIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "Fv+WgA6YgPHFKpt6JJCzJOlSMP6bLxbMnrJWSpPbcApNgsw1YWU3M3bCXc0JTwiruARehfCIdO2joTzbCr/caoci50QhaYDmePYkrHygEdAJFhRRo1G6gKGsZS3C6YH2WO1iiT1t+wYGm8hXqD1cLWwQbSUk7d2RUrDEcDaBGD6X2FOPcOCO4n2ajBl39cA1fj3cc5KHA4B0pN89MFfhbBN55PP7xafp44+wQTKZhqzWCP1f9O9svkcPBzqTM9zPBekiw7fW2mTRJbc1YTCYTCOr8aCE/gY3N0wBHpm9Jr57R3ITAYAh1INDL75pfcUMgUt4sx4k5jRrb1O3mCpq7w==" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "https://w3id.org/np/RAHUJfrVd0u0-nAFqQgnzaAqU1I8CjKXeyNlQFVJGc6zo" } ], "http://purl.org/nanopub/x/signedBy": [ { "@id": "https://w3id.org/np/RAWDFdbuQxoc9NE7suv9ZPpGeQJ4h_QVL67iJy5ZFaCYA/biochementity-bot" } ] } ] } ]